Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02567656 |
Title | Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Rhizen Pharmaceuticals SA |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
City of Hope | Duarte | California | 91010 | United States | Details | |
Chao Family Comprehensive Cancer Center University of California Irvine | Orange | California | 92868 | United States | Details | |
University of Colorado Cancer Center | Aurora | Colorado | 80045 | United States | Details | |
Emory University School of Medicine | Atlanta | Georgia | 30322 | United States | Details | |
University of Michigan Comprehensive Cancer Center | Ann Arbor | Michigan | 48109-0944 | United States | Details | |
Karmanos Cancer Institute | Detroit | Michigan | 48201 | United States | Details | |
University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106-5028 | United States | Details | |
MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |